all items  in current results   Refine your search within these categories: 1. Human Genes (group results) 1-acylglycerol-3-phosphate O-acyltransferases [HGNC:AGPAT] (11) 5-HT (serotonin) receptors [HGNC:HTR] (18) 7TM orphan receptors [HGNC:O7TM] (1) A-kinase anchor proteins [HGNC:AKAP] (24) Abhydrolase domain containing [HGNC:ABHD] (12) Acetylcholine receptors, nicotinic [HGNC:CHRN] (24) Acid-sensing (proton-gated) ion channels [HGNC:ASIC] (1) Actin related protein 2/3 complex subunits [HGNC:ARPC] (3) Acyl-CoA synthetase family [HGNC:ACS] (20) Acyl-CoA thioesterases [HGNC:ACOT] (7) more... 2. Interaction: Human Genes and Chemicals (group results) Affects (167) Decreases (174) Increases (180) 3. Bioactivity 4. Semantic Terms (group results) Entity [STY:T071] (44) A. Anatomy (group results) Body Regions [MESH:D001829] (89) Cardiovascular System [MESH:D002319] (88) Cells [MESH:D002477] (110) Digestive System [MESH:D004064] (56) Embryonic Structures [MESH:D004628] (25) Endocrine System [MESH:D004703] (59) Hemic and Immune Systems [MESH:D006424] (35) Integumentary System [MESH:D034582] (19) Musculoskeletal System [MESH:D009141] (93) Nervous System [MESH:D009420] (42) more... B. Organisms C01. Bacterial Infections and Mycoses (group results) Bacterial Infections [MESH:D001424] (153) Brain Abscess [MESH:D001922] (2) Central Nervous System Infections [MESH:D002494] (3) Infection [MESH:D007239] (157) Mycoses [MESH:D009181] (59) C02. Virus Diseases (group results) Virus Diseases [MESH:D014777] (174) C03. Parasitic Diseases (group results) Parasitic Diseases [MESH:D010272] (165) C04. Neoplasms (group results) Neoplasms [MESH:D009369] (196) C05. Musculoskeletal Diseases (group results) Musculoskeletal Diseases [MESH:D009140] (192) C06. Digestive System Diseases (group results) Digestive System Diseases [MESH:D004066] (196) C07. Stomatognathic Diseases (group results) Stomatognathic Diseases [MESH:D009057] (176) C08. Respiratory Tract Diseases (group results) Respiratory Tract Diseases [MESH:D012140] (194) Z. Exceptions (121) C09. Otorhinolaryngologic Diseases (group results) Otorhinolaryngologic Diseases [MESH:D010038] (162) C10. Nervous System Diseases (group results) Nervous System Diseases [MESH:D009422] (196) Z. Exceptions (162) C11. Eye Diseases (group results) Eye Diseases [MESH:D005128] (178) Z. Exceptions (42) C12. Male Urogenital Diseases (group results) Male Urogenital Diseases [MESH:D052801] (196) Z. Exceptions (2) C13. Female Urogenital Diseases and Pregnancy Complications (group results) Female Urogenital Diseases [MESH:D052776] (196) Pregnancy Complications [MESH:D011248] (187) Z. Exceptions (145) C14. Cardiovascular Diseases (group results) Cardiovascular Diseases [MESH:D002318] (196) Z. Exceptions (146) C15. Hemic and Lymphatic Diseases (group results) Hematologic Diseases [MESH:D006402] (180) Lymphatic Diseases [MESH:D008206] (179) Z. Exceptions (67) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results) Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] (196) Z. Exceptions (1) C17. Skin and Connective Tissue Diseases (group results) Connective Tissue Diseases [MESH:D003240] (173) Skin Diseases [MESH:D012871] (196) C18. Nutritional and Metabolic Diseases (group results) Metabolic Diseases [MESH:D008659] (196) Nutrition Disorders [MESH:D009748] (188) Z. Exceptions (104) C19. Endocrine System Diseases: all > Endocrine System Diseases [MESH:D004700] > Adrenal Gland Diseases [MESH:D000307] > Adrenal Hyperplasia, Congenital [MESH:D000312] > Adrenal hyperplasia, congenital, type 5 [MESH:C538237] C20. Immune System Diseases (group results) Immune System Diseases [MESH:D007154] (192) Z. Exceptions (62) C21. Disorders of Environmental Origin (group results) Disorders of Environmental Origin [MESH:D007280] (3) C22. Animal Diseases (group results) Animal Diseases [MESH:D000820] (180) C23. Pathological Conditions, Signs and Symptoms (group results) Pathologic Processes [MESH:D010335] (196) Pathological Conditions, Anatomical [MESH:D020763] (189) Signs and Symptoms [MESH:D012816] (196) C24. Occupational Diseases (group results) Occupational Diseases [MESH:D009784] (168) Z. Exceptions (122) C25. Chemically-Induced Disorders: all > Substance-Related Disorders [MESH:D019966] Alcohol-Related Disorders [MESH:D019973] (171) Amphetamine-Related Disorders [MESH:D019969] (153) Cocaine-Related Disorders [MESH:D019970] (177) Drug Overdose [MESH:D062787] (59) Marijuana Abuse [MESH:D002189] (111) Neonatal Abstinence Syndrome [MESH:D009357] (2) Opioid-Related Disorders [MESH:D009293] (121) Phencyclidine Abuse [MESH:D010623] (70) Psychoses, Substance-Induced [MESH:D011605] (148) Substance Withdrawal Syndrome [MESH:D013375] (148) more... C26. Wounds and Injuries (group results) Wounds and Injuries [MESH:D014947] (171) Z. Exceptions (137) D01. Inorganic Chemicals (group results) Arsenicals [MESH:D001152] (1) Cadmium Compounds [MESH:D019187] (1) Chlorine Compounds [MESH:D017606] (2) Electrolytes [MESH:D004573] (1) Elements [MESH:D004602] (5) Gases [MESH:D005740] (1) Metals [MESH:D008670] (3) Nitrogen Compounds [MESH:D017672] (2) Oxygen Compounds [MESH:D017601] (1) D02. Organic Chemicals (group results) Organic Chemicals [MESH:D009930] (105) D03. Heterocyclic Compounds (group results) Heterocyclic Compounds [MESH:D006571] (40) D04. Polycyclic Compounds (group results) Polycyclic Compounds [MESH:D011083] (40) D05. Macromolecular Substances D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) Hormones [MESH:D006728] (22) D08. Enzymes and Coenzymes D09. Carbohydrates (group results) Carbohydrates [MESH:D002241] (3) D10. Lipids (group results) Lipids [MESH:D008055] (15) D12. Amino Acids, Peptides, and Proteins (group results) Amino Acids [MESH:D000596] (2) Peptides [MESH:D010455] (7) Proteins [MESH:D011506] (4) D13. Nucleic Acids, Nucleotides, and Nucleosides (group results) Nucleotides [MESH:D009711] (3) D20. Complex Mixtures (group results) Complex Mixtures [MESH:D045424] (4) D23. Biological Factors (group results) Biological Factors [MESH:D001685] (9) D25. Biomedical and Dental Materials D26. Pharmaceutical Preparations (group results) Plant Extracts [MESH:D010936] (1) D27. Chemical Actions and Uses (group results) Pharmacologic Actions [MESH:D020228] (24) Specialty Uses of Chemicals [MESH:D020313] (5) Toxic Actions [MESH:D004786] (6) E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) Diagnosis [MESH:D003933] (119) F. Psychiatry and Psychology (group results) Behavior and Behavior Mechanisms [MESH:D001520] (106) Mental Disorders [MESH:D001523] (166) Psychological Phenomena and Processes [MESH:D011579] (9) G. Phenomena and Processes (group results) Chemical Phenomena [MESH:D055598] (14) Circulatory and Respiratory Physiological Phenomena [MESH:D002943] (69) Genetic Phenomena [MESH:D055614] (110) Musculoskeletal and Neural Physiological Phenomena [MESH:D055687] (28) Physiological Phenomena [MESH:D010829] (74) Reproductive and Urinary Physiological Phenomena [MESH:D012101] (9) I. Anthropology, Education, Sociology and Social Phenomena J. Technology, Industry, Agriculture (group results) Food and Beverages [MESH:D019602] (2) Technology, Industry, and Agriculture [MESH:D013676] (1) N. Health Care Recently Viewed Items Go to Item History

These terms define your current search. Click the × to remove a term. C19. Endocrine System Diseases: Endocrine System Diseases [MESH:D004700] > Adrenal Gland Diseases [MESH:D000307] > Adrenal Hyperplasia, Congenital [MESH:D000312] > Adrenal hyperplasia, congenital, type 5 [MESH:C538237] × C25. Chemically-Induced Disorders: Substance-Related Disorders [MESH:D019966] × 196 items, grouped by C25. Chemically-Induced Disorders (view ungrouped items) Alcohol-Related Disorders [MESH:D019973] (171)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C003060   pentachlorobenzene C003060               MESH:C004648   testosterone enanthate C004648               MESH:C004808   farnesyl pyrophosphate C004808               MESH:C005219   methyl cellosolve C005219               all 171 items... Amphetamine-Related Disorders [MESH:D019969] (153)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C003060   pentachlorobenzene C003060               MESH:C004648   testosterone enanthate C004648               MESH:C004808   farnesyl pyrophosphate C004808               MESH:C005219   methyl cellosolve C005219               all 153 items... Cocaine-Related Disorders [MESH:D019970] (177)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C003060   pentachlorobenzene C003060               MESH:C004648   testosterone enanthate C004648               MESH:C004808   farnesyl pyrophosphate C004808               MESH:C005219   methyl cellosolve C005219               all 177 items... Drug Overdose [MESH:D062787] (59)    MESH:C006253   pirinixic acid C006253               MESH:C006780   bisphenol A C006780               MESH:C009495   titanium dioxide C009495               MESH:C055238   1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene C055238               MESH:C056933   fumonisin B1 C056933               MESH:C057693   troglitazone C057693               all 59 items... Marijuana Abuse [MESH:D002189] (111)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C004648   testosterone enanthate C004648               MESH:C005219   methyl cellosolve C005219               MESH:C006253   pirinixic acid C006253               MESH:C006632   arsenic trioxide C006632               all 111 items... Neonatal Abstinence Syndrome [MESH:D009357] (2)    MESH:D010634   Phenobarbital D010634               MESH:D014635   Valproic Acid D014635               Opioid-Related Disorders [MESH:D009293] (121)    MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C004648   testosterone enanthate C004648               MESH:C004808   farnesyl pyrophosphate C004808               MESH:C005219   methyl cellosolve C005219               MESH:C006253   pirinixic acid C006253               MESH:C006632   arsenic trioxide C006632               all 121 items... Phencyclidine Abuse [MESH:D010623] (70)    MESH:C004648   testosterone enanthate C004648               MESH:C005219   methyl cellosolve C005219               MESH:C006253   pirinixic acid C006253               MESH:C006780   bisphenol A C006780               MESH:C008261   lead acetate C008261               MESH:C009495   titanium dioxide C009495               all 70 items... Psychoses, Substance-Induced [MESH:D011605] (148)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C003060   pentachlorobenzene C003060               MESH:C004648   testosterone enanthate C004648               MESH:C005219   methyl cellosolve C005219               MESH:C005445   triphenyl phosphate C005445               all 148 items... Substance Withdrawal Syndrome [MESH:D013375] (148)    MESH:C001277   geldanamycin C001277               MESH:C002963   geranylgeranyl pyrophosphate C002963               MESH:C003060   pentachlorobenzene C003060               MESH:C004648   testosterone enanthate C004648               MESH:C004808   farnesyl pyrophosphate C004808               MESH:C005219   methyl cellosolve C005219               all 148 items... Tobacco Use Disorder [MESH:D014029] (74)    MESH:C006253   pirinixic acid C006253               MESH:C006632   arsenic trioxide C006632               MESH:C006780   bisphenol A C006780               MESH:C008261   lead acetate C008261               MESH:C009495   titanium dioxide C009495               MESH:C010902   decabromobiphenyl ether C010902               all 74 items...